Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Yuanyuan Qu

机构:Shihezi University, Shanghai Medical College of Fudan University, Fudan University, Wenzhou Medical University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute, Zhongshan Hospital, First Affiliated Hospital of Shihezi University Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing Proteome Research Center · ORCID:0000-0003-1179-2800

发表论文 141 篇 · 总被引 2943 次 · h-index 29

代表论文

  • Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma (2024 · MedComm · 被引 49)
  • Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling. (2024 · European Journal of Pharmacology · 被引 35)
  • Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor (2023 · Nature Communications · 被引 30)
  • Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ (2023 · Nature Communications · 被引 25)
  • Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma (2023 · Cell Reports Medicine · 被引 24)
  • Detection, molecular function and mechanisms of m5C in cancer (2025 · Clinical and Translational Medicine · 被引 21)